GlassScriptPhysician profile
Katherine E Mcgoogan
NPI 1407051527
$23,859.65
in general payments reported to CMS, 2019-2025
17 companies · $11K in 2025
The $11K reported for 2025 was more than what 94% of Pediatric Gastroenterology providers received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $111 · 2022: $2,007 · 2023: $109 · 2024: $10K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Travel and Lodging: $2,710 · Food and Beverage: $2,347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,400.00 |
| Travel and Lodging | $2,710.38 |
| Food and Beverage | $2,347.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mirum Pharmaceuticals, INC. | $22,504.89 | 2022-2025 | Livmarli, Cholbam |
| Abbvie INC. | $408.71 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $259.06 | 2023-2025 | Gattex, Eohilia |
| Janssen Biotech, INC. | $178.76 | 2024-2025 | Stelara, Tremfya |
| Fresenius Kabi USA, LLC | $129.53 | 2025 | |
| Genzyme Corporation | $59.87 | 2024-2025 | |
| Qol Medical, LLC | $56.02 | 2022-2025 | Sucraid |
| Ipsen Biopharmaceuticals, INC | $55.17 | 2025 | Bylvay |
| Digestive Care, INC. | $39.87 | 2025 | Pertzye |
| Travere Therapeutics, INC. | $39.79 | 2019-2022 | |
| Shire North American Group INC | $34.53 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $28.63 | 2023 | Dupixent |
| Alexion Pharmaceuticals, INC. | $23.49 | 2019 | |
| Pharming Healthcare, INC. | $23.47 | 2025 | Ruconest |
| Mauna Kea Technologies, INC. | $17.86 | 2025 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Mcgoogan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.